English  |  正體中文  |  简体中文  |  2826208  
???header.visitor??? :  31905692    ???header.onlineuser??? :  1076
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"shih j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 676-700 of 1137  (46 Page(s) Totally)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-07-21T06:46:21Z Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression Yang P.-C.; Yu C.-J.; Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; CHAO-CHI HO; Shih J.-Y.; Chang Y.-L.
臺大學術典藏 2020-07-21T06:46:20Z Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.; Liao W.-Y.; Chen K.-Y.; Tseng H.-M.; Chen Y.-F.; CHAO-CHI HO; Shih J.-Y.; Xiao F.; Yang W.-C.
臺大學術典藏 2020-07-21T06:46:19Z Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum Liao W.-Y.; CHAO-CHI HO; Tsai T.-H.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2020-07-21T06:46:19Z Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; CHAO-CHI HO; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏 2020-07-21T06:46:19Z Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.; Shih J.-Y.
臺大學術典藏 2020-07-21T06:46:18Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Ko J.-C.; Shih J.-Y.; Liang S.-K.; Lee M.-R.; Liao W.-Y.; CHAO-CHI HO
臺大學術典藏 2020-07-21T06:46:18Z Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; Liao W.-Y.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.
臺大學術典藏 2020-07-21T06:46:17Z The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer Hsu C.-L.; Lin C.-K.; Liao W.-Y.; Yu K.-L.; Tsai T.-H.; CHAO-CHI HO; Shih J.-Y.
臺大學術典藏 2020-07-21T06:46:16Z Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients Yao Z.-H.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2020-07-21T06:46:16Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.; Chen J.-S.; Liao W.-Y.; CHAO-CHI HO; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2020-07-21T06:46:15Z Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y.
臺大學術典藏 2020-07-21T06:25:19Z RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer TZU-HSIU TSAI; Su K.-Y.; Wu S.-G.; Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-07-21T06:25:19Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Yang P.-C.; Shih J.-Y.; Yu C.-J.; Yang C.-H.; TZU-HSIU TSAI; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.
臺大學術典藏 2020-07-21T06:25:18Z BMVC test, an improved fluorescence assay for detection of malignant pleural effusions Shih J.-Y.; Lou P.-J.; Lin I.-T.;Tsai Y.-L.;Kang C.-C.;Huang W.-C.;Wang C.-L.;Lin M.-Y.;Lou P.-J.;Shih J.-Y.;Wang H.-C.;Wu H.-D.;Tzu-Hsiu Tsai;Jan I.-S.;Chang T.-C.; Lin I.-T.; Tsai Y.-L.; Kang C.-C.; Huang W.-C.; Wang C.-L.; Lin M.-Y.; Wang H.-C.; Wu H.-D.; TZU-HSIU TSAI; Jan I.-S.; Chang T.-C.
臺大學術典藏 2020-07-21T06:25:18Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tzu-Hsiu Tsai;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏 2020-07-21T06:25:18Z Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy Yang P.-C.; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yang C.-Y.; TZU-HSIU TSAI
臺大學術典藏 2020-07-21T06:25:17Z Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tzu-Hsiu Tsai;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; TZU-HSIU TSAI; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.
臺大學術典藏 2020-07-21T06:25:17Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Liao W.-Y.; Ho C.-C.; Liao B.-C.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tzu-Hsiu Tsai;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Yang J.C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; TZU-HSIU TSAI; Chen K.-Y.
臺大學術典藏 2020-07-21T06:25:17Z Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion Tzu-Hsiu Tsai;Wu S.-G.;Hsieh M.-S.;Yu C.-J.;Yang J.C.H.;Shih J.-Y.; TZU-HSIU TSAI; Wu S.-G.; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; Shih J.-Y.
臺大學術典藏 2020-07-21T06:25:17Z IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer Shih J.-Y.; Liu Y.-N.;Chang T.-H.;Tsai M.-F.;Wu S.-G.;Tzu-Hsiu Tsai;Chen H.-Y.;Yu S.-L.;Yang J.C.-H.;Shih J.-Y.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; TZU-HSIU TSAI; Chen H.-Y.; Yu S.-L.; Yang J.C.-H.
臺大學術典藏 2020-07-21T06:25:16Z The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer Yu K.-L.;Tzu-Hsiu Tsai;Ho C.-C.;Liao W.-Y.;Lin C.-K.;Hsu C.-L.;Shih J.-Y.; Yu K.-L.; TZU-HSIU TSAI; Ho C.-C.; Liao W.-Y.; Lin C.-K.; Hsu C.-L.; Shih J.-Y.
臺大學術典藏 2020-07-21T06:25:16Z Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer Shih J.-Y.; Gow C.-H.;Liu Y.-N.;Li H.-Y.;Hsieh M.-S.;Chang S.-H.;Luo S.-C.;Tzu-Hsiu Tsai;Chen P.-L.;Tsai M.-F.;Shih J.-Y.; Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; TZU-HSIU TSAI; Chen P.-L.; Tsai M.-F.
臺大學術典藏 2020-07-21T06:25:16Z Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum Liao W.-Y.;Ho C.-C.;Tzu-Hsiu Tsai;Chen K.-Y.;Shih J.-Y.;Yu C.-J.; Liao W.-Y.; Ho C.-C.; TZU-HSIU TSAI; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2020-07-21T06:25:15Z Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors Shih J.-Y.; Liao W.-Y.; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Liao W.-Y.;Shih J.-Y.;Yu C.-J.;Chen K.-Y.;Tzu-Hsiu Tsai;Yang J.C.-H.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Yang J.C.-H.; Yu C.-J.; Chen K.-Y.; TZU-HSIU TSAI
臺大學術典藏 2020-07-21T06:25:15Z Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tzu-Hsiu Tsai;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; TZU-HSIU TSAI; Gow C.-H.; Chang Y.-L.; Shih J.-Y.

Showing items 676-700 of 1137  (46 Page(s) Totally)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
View [10|25|50] records per page